Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for LymphomaAnna Barata, Heather Jim, Kedar Kirtane et al.|Transplantation and Cellular Therapy|2022Cited by 58
Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell TherapyAasha I. Hoogland, Heather Jim, Anna Barata et al.|Transplantation and Cellular Therapy|2022Cited by 44
Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucelAasha I. Hoogland, Heather Jim, Reena Jayani et al.|Cancer Medicine|2021Cited by 35
Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapyAnna Barata, Heather Jim, Aasha I. Hoogland et al.|Psycho-Oncology|2021Cited by 24
Subjective cognition in chimeric antigen receptor T-cell therapy recipients.Anna Barata, Heather Jim, Aasha I. Hoogland et al.|Journal of Clinical Oncology|2020Cited by 1